These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 824496)

  • 1. Human C-peptide. Part II: Clinical studies.
    Beischer W; Heinze E; Keller L; Raptis S; Kerner W; Pfeiffer EF
    Klin Wochenschr; 1976 Aug; 54(15):717-25. PubMed ID: 824496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics.
    Kumar MS; Schumacher OP; Deodhar SD
    Am J Clin Pathol; 1980 Jul; 74(1):78-82. PubMed ID: 6994486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human C-peptide in normal and diabetic subjects.
    Heding LG; Rasmussen SM
    Diabetologia; 1975 Jun; 11(3):201-6. PubMed ID: 1149953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
    Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
    Ludvigsson J; Heding L
    Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of free and total insulin and C-peptide in insulin-treated diabetics.
    Kuzuya H; Blix PM; Horwitz DL; Steiner DF; Rubenstein AH
    Diabetes; 1977 Jan; 26(1):22-9. PubMed ID: 830562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-peptide response to oral glucose in low insulin responders, subdiabetic, and diabetic subjects.
    Toyota T; Kudo M; Abe K; Goto Y
    Tohoku J Exp Med; 1977 Feb; 121(2):99-104. PubMed ID: 847746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
    Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 14. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.
    Ludvigsson J; Heding LG
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):364-71. PubMed ID: 577329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide in juvenile diabetes.
    Ludvigsson J; Heding LG
    Acta Paediatr Scand Suppl; 1977; (270):53-62. PubMed ID: 356517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunological determination of human C-peptide in serum.
    Heding LG
    Diabetologia; 1975 Dec; 11(6):541-8. PubMed ID: 1239396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.